Sam Schulman

Hematologist
McMaster University
Hamilton, Ontario, Canada

Presentation(s):

• PB0082 - Investigating inter-assay variability between DOAC calibrated anti-factor Xa assays: A substudy of the PAUSE trial.

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 20.4 - Preoperative DOAC Levels are Associated with Postoperative Bleeding and Effects are Mediated by Thrombin Generation Parameters - [SONAR]: A Nested Case-Control Study and Causal Mediation Analysis

  Sunday, June 23, 2024
  15:30 – 15:45 ICT

• SSC 013.7 - Registry on augmented antithrombotic treatment regimens for patients with arterial thrombotic APS

  Monday, June 24, 2024
  17:45 – 17:55 ICT

• SSC 017.2 - ISTH Guideline for Antithrombic Treatment in COVID19: an update

  Monday, June 24, 2024
  16:35 – 16:50 ICT

• OC 60.2 - Bleeding during initial and extended anticoagulant treatment in VTE patients compared to matched population controls without anticoagulant medication – a Swedish nationwide register-based study.

  Tuesday, June 25, 2024
  15:00 – 15:15 ICT

• OC 74.4 - Time trends in one-year mortality after a first venous thromboembolism – a Swedish nationwide register-based study.

  Wednesday, June 26, 2024
  11:00 – 11:15 ICT